IRON Disc Medicine, Inc. - Common Stock
$80.86
价格 · 八月 19, 2026
截至...的财报数据 七月 30, 2026
52周区间
$56–$100
58% of range
分析师评级
BUY
19 analysts
目标价
$101
+25% upside
P/E (TTM)
-13.5
ROE
-31.3%
净利润率
—
IRON 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$80.86
市值
$3.06B
P/E (TTM)
-13.5
每股收益 (TTM)
$-6.01
营收 (TTM)
—
股息收益率
—
ROE
-31.3%
负债/权益
—
52周区间
$56 – $100
IRON 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-6.01
2021-12-31
→
2025-12-31
自由现金流
$-181M
2021-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
IRON
同行中位数
P/E (TTM)
-13.5
—
P/B (市净率)
4.1
3.3
Price / FCF (股价/自由现金流)
-16.9
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
IRON
同行中位数
ROA
-32.6%
-36.2%
ROE
-31.3%
-43.7%
ROIC
-32.0%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
IRON
同行中位数
Current Ratio (流动比率)
21.9
9.7
Quick Ratio (速动比率)
21.6
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
IRON
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
IRON
同行中位数
IRON 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
19 位分析师
- 强烈买入 7 36.8%
- 买入 11 57.9%
- 持有 1 5.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
12 位分析师 · 2026-08-15
中位数
$100.00
现在
$80.86
最低
$79.00
最高
$128.00
中位数目标
$100.00
+23.7%
平均目标
$101.17
+25.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-1.54 | $-1.78 | 0.24% |
| 2026年3月31日 | $-1.65 | $-1.75 | 0.10% |
| 2025年12月31日 | $-1.64 | $-1.78 | 0.14% |
| 2025年9月30日 | $-1.77 | $-1.49 | -0.28% |
| 2025年6月30日 | $-1.58 | $-1.18 | -0.40% |
| 2025年3月31日 | $-1.02 | $-1.16 | 0.14% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $171M | $97M | $69M | $33M | $25M | $28M | |
| SG&A Expense | $65M | $33M | $22M | $14M | $6M | $6M | |
| Operating Expenses | $236M | $130M | $91M | $47M | $31M | $34M | |
| Operating Income | $-236M | $-130M | $-91M | $-47M | $-31M | $-34M | |
| Interest Expense | · | · | · | · | $2M | $7M | |
| Other Non-op | $45.0K | $-2.0K | $-2.0K | $0 | $-5M | · | |
| Pretax Income | $-212M | $-109M | $-76M | $-47M | · | · | |
| Income Tax | $361.0K | $355.0K | $99.0K | $0 | · | · | |
| Net Income | $-212M | $-109M | $-76M | $-47M | $-36M | $-41M | |
| EPS (Basic) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | · | |
| EPS (Diluted) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | · | |
| Shares (Basic) | 35,295,663 | 27,606,022 | 22,315,877 | 1,039,490 | 878,407 | · | |
| Shares (Diluted) | 35,295,663 | 27,606,022 | 22,315,877 | 1,039,490 | 878,407 | · | |
| EBITDA | $-236M | $-130M | $-91M | $-47M | $-69M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $91M | $192M | $360M | $195M | $88M | $5M | |
| Short-term Investments | $700M | $297M | $0 | · | · | · | |
| Prepaid Expense | $13M | $4M | $5M | $4M | $2M | $562.0K | |
| Current Assets | $804M | $494M | $366M | $198M | $90M | $5M | |
| PP&E (Net) | $1M | $751.0K | $170.0K | $168.0K | $106.0K | $294.0K | |
| PP&E (Gross) | · | · | · | · | $0 | $955.0K | |
| Accum. Depreciation | · | $401.0K | $245.0K | $145.0K | $56.0K | $661.0K | |
| Other Non-current Assets | $726.0K | $838.0K | $234.0K | $116.0K | $180.0K | · | |
| Total Assets | $807M | $497M | $368M | $200M | $92M | $8M | |
| Accounts Payable | $9M | $8M | $13M | $16M | $3M | $2M | |
| Accrued Liabilities | $16M | $8M | $6M | $6M | $4M | $492.6K | |
| Current Liabilities | $37M | $23M | $21M | $23M | $13M | $25M | |
| Capital Leases | $1M | $2M | $1M | $1M | $1M | · | |
| Total Liabilities | $67M | $53M | $23M | $24M | $15M | $30M | |
| Long-term Debt | $29M | $28M | $0 | · | · | $14M | |
| Common Stock | $4.0K | $3.0K | $2.0K | $2.0K | $0 | $2.0K | |
| Paid-in Capital | $1.25B | $741M | $534M | $289M | $1M | $91M | |
| Retained Earnings | $-510M | $-298M | $-189M | $-112M | $-65M | $-113M | |
| AOCI | $965.0K | $289.0K | $0 | · | · | · | |
| Stockholders' Equity | $740M | $444M | $345M | $177M | $-64M | $-29M | |
| Liabilities + Equity | $807M | $497M | $368M | $200M | $92M | $8M | |
| Shares Outstanding | 37,890,616 | 29,865,030 | 24,360,233 | 17,403,315 | 909,418 | 15,565,380 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $281.0K | $156.0K | $100.0K | $89.0K | $32.0K | · | |
| Stock-based Comp | $34M | $17M | $6M | $2M | $507.0K | $983.0K | |
| Deferred Tax | $0 | · | · | · | · | · | |
| Other Non-cash | $-3M | $-2M | $-3M | $2M | · | · | |
| Operating Cash Flow | $-180M | $-94M | $-73M | $-42M | $-28M | $-33M | |
| CapEx | $933.0K | $505.0K | $89.0K | $151.0K | $68.0K | $22.0K | |
| Investing Cash Flow | $-394M | $-292M | $-89.0K | $-151.0K | $-68.0K | $-22.0K | |
| Debt Issued | $0 | $29M | $0 | · | · | · | |
| Net Debt Issued | $0 | $29M | · | · | · | · | |
| Stock Issued | · | · | $0 | $54M | $0 | $20M | |
| Net Stock Activity | · | · | $0 | $54M | $0 | · | |
| Financing Cash Flow | $473M | $218M | $239M | $149M | $90M | $34M | |
| Net Change in Cash | $-101M | $-168M | $166M | $107M | $62M | $2M | |
| Taxes Paid | $349.0K | $300.0K | $100.0K | $0 | $0 | · | |
| Free Cash Flow | $-181M | $-94M | $-74M | $-42M | $-60M | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -32.6% | -25.3% | -26.9% | -32.0% | -96.6% | · | |
| ROE | -31.3% | -24.0% | -21.7% | -120.0% | -54.1% | · | |
| ROIC | -32.0% | -29.3% | -26.4% | · | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.9 | 21.2 | 17.1 | 8.8 | 9.4 | 2.2 | |
| Quick Ratio | 21.6 | 21.0 | 16.8 | 8.6 | 9.2 | 2.0 | |
| Interest Coverage | · | · | · | · | -32.0 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-212M | $-109M | $-76M | $-47M | $-36M | $-41M | |
| Market Cap | $3.01B | $1.89B | $1.41B | $346M | $3.77B | · | |
| P/E | -13.2 | -16.0 | -16.9 | -0.4 | -2.1 | · | |
| P/B | 4.1 | 4.3 | 4.1 | 2.0 | 30.2 | · | |
| P / Tangible Book | 4.1 | 4.3 | 4.1 | 2.0 | · | · | |
| P / Cash Flow | -16.7 | -20.2 | -19.2 | -8.2 | -63.2 | · | |
| P / FCF | -16.6 | -20.1 | -19.1 | -8.2 | -63.1 | · | |
| Earnings Yield | -7.6% | -6.2% | -5.9% | -226.5% | -46.9% | · |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $46M | $46M | $50M | $46M | $28M | $25M | $25M | $23M | $24M | $23M | $14M | $12M | $20M | $10M | $8M | |
| SG&A Expense | $18M | $24M | $21M | $17M | $15M | $12M | $10M | $8M | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $3M | |
| Operating Expenses | $65M | $70M | $67M | $68M | $61M | $40M | $35M | $33M | $31M | $31M | $30M | $19M | $17M | $25M | $15M | $10M | |
| Operating Income | $-65M | $-70M | $-67M | $-68M | $-61M | $-40M | $-35M | $-33M | $-31M | $-31M | $-30M | $-19M | $-17M | $-25M | $-15M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $41.0K | |
| Other Non-op | $-12.0K | $22.0K | $-2.0K | $-18.0K | $68.0K | $-3.0K | $3.0K | $9.0K | $-13.0K | $-1.0K | $-10.0K | $13.0K | $-5.0K | $0 | $-107.0K | $0 | |
| Pretax Income | $-59M | $-63M | $-60M | $-62M | $-55M | $-34M | $-29M | $-26M | $-26M | $-27M | $-24M | $-14M | $-16M | $-23M | $-11M | $-16M | |
| Income Tax | $69.0K | $51.0K | $88.0K | $102.0K | $52.0K | $119.0K | $176.0K | $114.0K | $60.0K | $5.0K | $32.0K | $20.0K | $24.0K | $23.0K | $0 | $0 | |
| Net Income | $-60M | $-64M | $-61M | $-62M | $-55M | $-34M | $-29M | $-27M | $-26M | $-27M | $-24M | $-14M | $-16M | $-23M | $-11M | $-16M | |
| EPS (Basic) | $-1.54 | $-1.65 | $-1.64 | $-1.77 | $-1.58 | $-1.02 | $-0.95 | $-0.89 | $-1.03 | $-1.09 | $-0.90 | $-0.58 | $-0.74 | $-1.20 | $-7.42 | $-16.82 | |
| EPS (Diluted) | $-1.54 | $-1.65 | $-1.64 | $-1.77 | $-1.58 | $-1.02 | $-0.95 | $-0.89 | $-1.03 | $-1.09 | $-0.90 | $-0.58 | $-0.74 | $-1.20 | $-7.42 | $-16.82 | |
| Shares (Basic) | 38,685,565 | 38,491,433 | -68,232,365 | 35,178,691 | 35,024,592 | 33,324,745 | -52,788,441 | 29,935,551 | 25,649,043 | 24,809,869 | -42,440,809 | 24,316,817 | 21,484,955 | 18,954,914 | -1,789,283 | 960,317 | |
| Shares (Diluted) | 38,685,565 | 38,491,433 | -68,232,365 | 35,178,691 | 35,024,592 | 33,324,745 | -52,788,441 | 29,935,551 | 25,649,043 | 24,809,869 | -42,440,809 | 24,316,817 | 21,484,955 | 18,954,914 | -1,789,283 | 960,317 | |
| EBITDA | $-65M | $-69M | · | $-68M | $-61M | $-40M | · | $-33M | $-31M | $-31M | · | $-19M | $-17M | $-25M | · | $-4M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $89M | $91M | $141M | $127M | $123M | $192M | $193M | $281M | $343M | · | $371M | $378M | $236M | $195M | $102M | |
| Short-term Investments | $619M | $641M | $700M | $475M | $523M | $572M | $297M | $295M | $220M | · | · | · | · | · | · | · | |
| Prepaid Expense | $15M | $17M | $13M | $11M | $12M | $11M | $4M | $6M | $7M | $9M | · | $4M | $4M | $6M | $4M | $3M | |
| Current Assets | $733M | $747M | $804M | $627M | $662M | $706M | $494M | $493M | $508M | $352M | · | $374M | $382M | $242M | $198M | $105M | |
| PP&E (Net) | $980.0K | $1M | $1M | $1M | $1M | $1M | $751.0K | $79.0K | $98.0K | $211.0K | · | $183.0K | $159.0K | $180.0K | $168.0K | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | $392.0K | $381.0K | $271.0K | · | $220.0K | $195.0K | $170.0K | $145.0K | · | |
| Other Non-current Assets | $496.0K | $721.0K | $726.0K | $840.0K | $840.0K | $839.0K | $838.0K | $236.0K | $236.0K | $235.0K | · | $116.0K | $116.0K | $116.0K | $116.0K | $1M | |
| Total Assets | $735M | $750M | $807M | $630M | $665M | $709M | $497M | $495M | $510M | $354M | · | $376M | $384M | $244M | $200M | $106M | |
| Accounts Payable | $7M | $12M | $9M | $7M | $6M | $7M | $8M | $4M | $5M | $5M | · | $8M | $5M | $6M | $16M | $1M | |
| Accrued Liabilities | $9M | $7M | $16M | $11M | $6M | $4M | $8M | $6M | $4M | $9M | · | $6M | $4M | $4M | $6M | · | |
| Current Liabilities | $30M | $31M | $37M | $27M | $21M | $19M | $23M | $25M | $20M | $15M | · | $14M | $10M | $10M | $23M | $1M | |
| Capital Leases | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | · | $2M | $2M | $945.0K | $1M | · | |
| Total Liabilities | $91M | $62M | $67M | $57M | $51M | $49M | $53M | $27M | $21M | $16M | · | $18M | $13M | $11M | $24M | $1M | |
| Long-term Debt | $59M | $29M | $29M | $29M | $29M | $29M | $28M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | |
| Paid-in Capital | $1.28B | $1.26B | $1.25B | $1.02B | $1.00B | $992M | $741M | $736M | $731M | $554M | · | $524M | $522M | $368M | $289M | $315M | |
| Retained Earnings | $-633M | $-574M | $-510M | $-450M | $-387M | $-332M | $-298M | $-269M | $-242M | $-216M | · | $-165M | $-151M | $-135M | $-112M | $-210M | |
| AOCI | $-2M | $-571.0K | $965.0K | $718.0K | $273.0K | $535.0K | $289.0K | $741.0K | $-60.0K | · | · | · | · | · | · | · | |
| Stockholders' Equity | $644M | $688M | $740M | $573M | $614M | $660M | $444M | $468M | $489M | $338M | $345M | $359M | $371M | $233M | $177M | $105M | |
| Liabilities + Equity | $735M | $750M | $807M | $630M | $665M | $709M | $497M | $495M | $510M | $354M | · | $376M | $384M | $244M | $200M | $106M | |
| Shares Outstanding | 38,345,666 | 38,190,464 | 37,890,616 | 35,006,636 | 34,694,882 | 34,581,222 | 29,865,030 | 29,748,154 | 29,707,997 | 24,695,885 | · | 24,139,078 | 22,850,894 | 19,575,242 | 17,403,315 | 43,299,453 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90.0K | $89.0K | $89.0K | $87.0K | $85.0K | $20.0K | $9.0K | $11.0K | $110.0K | $26.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $24.0K | |
| Stock-based Comp | $14M | $12M | $10M | $10M | $8M | $6M | $4M | $4M | $4M | $4M | $2M | $1M | $1M | $1M | $993.0K | $-3M | |
| Other Non-cash | · | $-11M | · | · | · | $-14M | · | · | · | $-11M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-44M | $-62M | $-43M | $-48M | $-48M | $-41M | $-28M | $-17M | $-15M | $-34M | $-18M | $-7M | $-13M | $-35M | $-10M | $-7M | |
| CapEx | $0 | $0 | $20.0K | $26.0K | $36.0K | $851.0K | $449.0K | $-8.0K | $-3.0K | $67.0K | $3.0K | $45.0K | $12.0K | $29.0K | $12.0K | $19.0K | |
| Investing Cash Flow | $22M | $58M | $-223M | $50M | $52M | $-273M | $-1M | $-71M | $-220M | $-67.0K | $-3.0K | $-45.0K | $-12.0K | $-29.0K | $-12.0K | $-19.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | · | |
| Financing Cash Flow | $32M | $2M | $217M | $12M | $892.0K | $244M | $29M | $426.0K | $173M | $16M | $8M | $460.0K | $154M | $77M | $149M | $3M | |
| Net Change in Cash | $10M | $-2M | $-50M | $13M | $5M | $-70M | $-202.0K | $-88M | $-62M | $-18M | $-10M | $-7M | $141M | $42M | $139M | $-4M | |
| Taxes Paid | · | · | · | · | · | · | $263.0K | $4.0K | $33.0K | $0 | $22.0K | $78.0K | $0 | $0 | $0 | · | |
| Free Cash Flow | · | $-62M | · | · | · | $-42M | · | · | · | $-34M | · | · | · | $-35M | · | · |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.5% | -8.7% | · | -11.1% | -9.4% | -6.4% | · | -6.1% | -5.9% | -9.0% | · | -5.9% | -6.4% | -12.4% | · | -2.5% | |
| ROE | -9.5% | -9.4% | · | -12.0% | -10.0% | -6.8% | · | -6.4% | -6.1% | -9.4% | · | -6.1% | -6.7% | -13.2% | · | -2.7% | |
| ROIC | -10.1% | -10.1% | · | -11.8% | -10.0% | -6.1% | · | -7.0% | -6.3% | -9.3% | · | -5.3% | -4.7% | -10.8% | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.1 | 24.0 | · | 23.5 | 32.1 | 37.7 | · | 19.4 | 25.0 | 23.7 | · | 26.0 | 39.4 | 24.3 | · | 71.5 | |
| Quick Ratio | 23.6 | 23.4 | · | 23.0 | 31.5 | 37.1 | · | 19.1 | 24.7 | 23.1 | · | 25.7 | 39.0 | 23.7 | · | 69.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -91.1 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-241M | $-215M | · | $-178M | $-142M | $-114M | · | $-94M | $-83M | $-80M | · | $-69M | $-64M | $-58M | · | $-54M | |
| Market Cap | $2.80B | $2.44B | · | $2.31B | $1.84B | $1.72B | · | $1.46B | $1.34B | $1.54B | · | $1.13B | $1.01B | $415M | · | $2.13B | |
| P/E | -11.2 | -10.6 | · | -12.6 | -11.7 | -12.3 | · | -13.7 | -13.1 | -17.2 | · | -2.4 | -1.5 | -0.5 | · | -1.3 | |
| P/B | 4.4 | 3.5 | · | 4.0 | 3.0 | 2.6 | · | 3.1 | 2.7 | 4.5 | · | 3.2 | 2.7 | 1.8 | · | 20.4 | |
| P / Tangible Book | 4.4 | 3.5 | · | 4.0 | 3.0 | 2.6 | · | 3.1 | 2.7 | 4.5 | · | 3.2 | 2.7 | 1.8 | · | 20.4 | |
| P / Cash Flow | · | -39.2 | · | · | · | -41.5 | · | · | · | -45.8 | · | · | · | -11.7 | · | · | |
| P / FCF | · | -39.2 | · | · | · | -40.7 | · | · | · | -45.7 | · | · | · | -11.7 | · | · | |
| Earnings Yield | -8.9% | -9.4% | · | -8.0% | -8.5% | -8.1% | · | -7.3% | -7.6% | -5.8% | · | -41.2% | -65.1% | -183.2% | · | -77.4% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-212M | $-109M | $-76M | $-47M | $-36M |
| 稀释后每股收益 (EPS) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 21.9 | 21.2 | 17.1 | 8.8 | 9.4 |
| 速动比率 | 21.6 | 21.0 | 16.8 | 8.6 | 9.2 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-181M | $-94M | $-74M | $-42M | $-60M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 239 家申报者 · $2.5B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 52 (+3 与上一季度对比) | 21 (-16 与上一季度对比) | 73 (-9 与上一季度对比) | 64 (+24 与上一季度对比) | +3.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $206953287 | 2829550 | 8.25% | 股份 |
| RA CAPITAL MANAGEMENT, L.P. | $179209164 | 2450221 | 7.14% | 股份 |
| VANGUARD GROUP INC | $120966365 | 1523314 | 4.82% | 股份 |
| STATE STREET CORP | $120595865 | 1648836 | 4.81% | 股份 |
| Vestal Point Capital, LP | $113367000 | 1550000 | 4.52% | 股份 |
| Atlas Venture Life Science Advisors, LLC | $110724818 | 1513875 | 4.41% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $100130635 | 1369027 | 3.99% | 股份 |
| Frazier Life Sciences Management, L.P. | $99093875 | 1354852 | 3.95% | 股份 |
| TCG Crossover Management, LLC | $98143787 | 1341862 | 3.91% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $90922967 | 1243136 | 3.62% | 股份 |
| BVF INC/IL | $84375182 | 1153612 | 3.36% | 股份 |
| Woodline Partners LP | $70088672 | 958281 | 2.79% | 股份 |
| Siren, L.L.C. | $64977649 | 888401 | 2.59% | 股份 |
| Logos Global Management LP | $63997500 | 875000 | 2.55% | 股份 |
| Opaleye Management Inc. | $62534700 | 855000 | 2.49% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $49411270 | 675408 | 1.97% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $48052980 | 657000 | 1.92% | 股份 |
| Bellevue Group AG | $40958400 | 560000 | 1.63% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $39242462 | 536539 | 1.56% | 股份 |
| Saturn V Capital Management LP | $38378752 | 524730 | 1.53% | 股份 |
| ARMISTICE CAPITAL, LLC | $33644400 | 460000 | 1.34% | 股份 |
| JENNISON ASSOCIATES LLC | $32146492 | 439520 | 1.28% | 股份 |
| Aberdeen Group plc | $32048046 | 438174 | 1.28% | 股份 |
| Palo Alto Investors LP | $30473488 | 416646 | 1.21% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $28938480 | 395651 | 1.15% | 股份 |
| Pictet Asset Management Holding SA | $28186328 | 385375 | 1.12% | 股份 |
| Assenagon Asset Management S.A. | $28097316 | 384158 | 1.12% | 股份 |
| Foresite Capital Management V, LLC | $27359407 | 374069 | 1.09% | 股份 |
| ORBIMED ADVISORS LLC | $26150110 | 357535 | 1.04% | 股份 |
| BAKER BROS. ADVISORS LP | $25573913 | 349657 | 1.02% | 股份 |
| LOOMIS SAYLES & CO L P | $23226924 | 317568 | 0.93% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20620872 | 281937 | 0.82% | 股份 |
| Octagon Capital Advisors LP | $19747800 | 270000 | 0.79% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18824919 | 257382 | 0.75% | 股份 |
| Checkpoint Capital L.P. | $17562743 | 240125 | 0.70% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $16470982 | 225198 | 0.66% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $13508592 | 184695 | 0.54% | 股份 |
| Catalio Capital Management, LP | $11657346 | 159384 | 0.46% | 股份 |
| Caption Management, LLC | $10971000 | 150000 | 0.44% | 买入期权 |
| Sofinnova Investments, Inc. | $10695920 | 146239 | 0.43% | 股份 |
| Bain Capital Life Sciences Investors, LLC | $10329855 | 141234 | 0.41% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $10001895 | 136750 | 0.40% | 股份 |
| Alyeska Investment Group, L.P. | $9142500 | 125000 | 0.36% | 股份 |
| Ensign Peak Advisors, Inc | $8931199 | 122111 | 0.36% | 股份 |
| Trexquant Investment LP | $7877105 | 107699 | 0.31% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $7809085 | 106769 | 0.31% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $7770979 | 106248 | 0.31% | 股份 |
| BANK OF AMERICA CORP /DE/ | $6884814 | 94132 | 0.27% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $6055992 | 82800 | 0.24% | 股份 |
| Squarepoint Ops LLC | $5549278 | 75872 | 0.22% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5383104 | 73600 | 0.21% | 买入期权 |
| DNB Asset Management AS | $5348509 | 73127 | 0.21% | 股份 |
| GOLDMAN SACHS GROUP INC | $4960721 | 67825 | 0.20% | 股份 |
| Casdin Capital, LLC | $4754100 | 65000 | 0.19% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $4647169 | 63538 | 0.19% | 股份 |
| Bank of New York Mellon Corp | $4572786 | 62521 | 0.18% | 股份 |
| PEAK6 LLC | $4388400 | 60000 | 0.17% | 买入期权 |
| KVP Capital Advisors, LP | $4260405 | 58250 | 0.17% | 股份 |
| MOORE CAPITAL MANAGEMENT, LP | $4227199 | 57796 | 0.17% | 股份 |
| XTX Topco Ltd | $4147769 | 56710 | 0.17% | 股份 |
| NEXTBio Capital Management LP | $3851187 | 52655 | 0.15% | 股份 |
| ALGERT GLOBAL LLC | $3792309 | 51850 | 0.15% | 股份 |
| ExodusPoint Capital Management, LP | $3775706 | 51623 | 0.15% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $3700713 | 49674 | 0.15% | 股份 |
| Burkehill Global Management, LP | $3657000 | 50000 | 0.15% | 股份 |
| Swiss National Bank | $3642372 | 49800 | 0.15% | 股份 |
| AMERIPRISE FINANCIAL INC | $3355224 | 45874 | 0.13% | 股份 |
| Atle Fund Management AB | $3194901 | 43682 | 0.13% | 股份 |
| Quadrature Capital Ltd | $3102526 | 42419 | 0.12% | 股份 |
| Brevan Howard Capital Management LP | $3063542 | 41886 | 0.12% | 股份 |
| ALPS ADVISORS INC | $2820644 | 38565 | 0.11% | 股份 |
| CITIGROUP INC | $2683068 | 36684 | 0.11% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2679411 | 36634 | 0.11% | 股份 |
| RHUMBLINE ADVISERS | $2621620 | 35844 | 0.10% | 股份 |
| LAZARD ASSET MANAGEMENT LLC | $2562387 | 35034 | 0.10% | 股份 |
| SEVEN GRAND MANAGERS, LLC | $2559900 | 35000 | 0.10% | 股份 |
| MARSHALL WACE, LLP | $2515577 | 34394 | 0.10% | 股份 |
| BANK OF MONTREAL /CAN/ | $2359350 | 32258 | 0.09% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $2216800 | 34670 | 0.09% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2198385 | 34382 | 0.09% | 股份 |
| RTW INVESTMENTS, LP | $2194200 | 30000 | 0.09% | 股份 |
| Squadron Capital Management LLC | $2194200 | 30000 | 0.09% | 买入期权 |
| VICTORY CAPITAL MANAGEMENT INC | $2129618 | 29117 | 0.08% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $2096412 | 28663 | 0.08% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2031171 | 27771 | 0.08% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $1966588 | 26888 | 0.08% | 股份 |
| Rafferty Asset Management, LLC | $1943037 | 26566 | 0.08% | 股份 |
| Campbell & CO Investment Adviser LLC | $1870044 | 25568 | 0.07% | 股份 |
| BlackRock, Inc. | $1617491 | 22115 | 0.06% | 股份 |
| TD Asset Management Inc | $1579824 | 21600 | 0.06% | 股份 |
| Engineers Gate Manager LP | $1430033 | 19552 | 0.06% | 股份 |
| DLD Asset Management, LP | $1330238 | 18200 | 0.05% | 卖出期权 |
| CITADEL ADVISORS LLC | $1258008 | 17200 | 0.05% | 卖出期权 |
| MetLife Investment Management, LLC | $1213246 | 16588 | 0.05% | 股份 |
| CITADEL ADVISORS LLC | $1199203 | 16396 | 0.05% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1178359 | 16111 | 0.05% | 股份 |
| CITADEL ADVISORS LLC | $1155612 | 15800 | 0.05% | 买入期权 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1128477 | 15429 | 0.04% | 股份 |
| Man Group plc | $1091615 | 14925 | 0.04% | 股份 |
| HighVista Strategies LLC | $1039978 | 14219 | 0.04% | 股份 |
公司内部人士 30 位内幕人士 · 12 位高管 · 16 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| John D Quisel | Chief Executive Officer | 2026年8月17日 M | 226064 | 0 | 14 | $-12028932 |
| Jason Patrick Meyenburg | Chief Executive Officer | 2022年1月3日 A | 13000 | 0 | 0 | $0 |
| Jean M. Franchi | Chief Financial Officer | 2026年4月14日 S | 64333 | 0 | 6 | $-1204945 |
| Joanne Bryce | Chief Financial Officer | 2024年1月10日 A | 23665 | 0 | 0 | $0 |
| Brian Piekos | CFO | 2022年5月31日 A | 17615 | 0 | 0 | $0 |
| William Jacob Savage | Chief Medical Officer | 2026年4月13日 S | 79480 | 0 | 8 | $-2265589 |
| Pamela Stephenson | Chief Commercial Officer | 2026年2月17日 S | 80998 | 0 | 1 | $-347679 |
| Brian Richard Macdonald | Chief Innovation Officer | 2023年6月30日 S | 12276 | 0 | 0 | $0 |
| Walter Strapps | Chief Scientific Officer | 2021年4月29日 A | — | 0 | 0 | $0 |
| Samuel B. Barone | Chief Medical Officer | 2021年4月12日 A | — | 0 | 0 | $0 |
| Marc Uknis | Chief Medical Officer | 2021年2月5日 A | — | 0 | 0 | $0 |
| Scott Lauder | Chief Technology Officer | 2021年2月5日 A | — | 0 | 0 | $0 |
| Donald William Nicholson | 董事 | 2026年6月18日 A | — | 0 | 0 | $0 |
| William Richard White | 董事 | 2026年6月18日 A | 0 | 0 | 0 | $0 |
| Mark Chin | 董事 | 2026年6月18日 A | — | 0 | 0 | $0 |
| Nadim Ahmed | 董事 | 2026年6月18日 A | — | 0 | 0 | $0 |
| Kevin Bitterman | 董事 | 2026年6月18日 A | 14161 | 0 | 19 | $-16858638 |
| Liam Ratcliffe | 董事 | 2026年6月18日 A | — | 0 | 0 | $0 |
| Georges Gemayel | 董事 | 2026年6月18日 A | — | 0 | 0 | $0 |
| Mona Ashiya | 董事 | 2025年6月11日 A | 186541 | 0 | 0 | $0 |
| Jay T. Backstrom | 董事 | 2022年12月29日 A | — | 0 | 0 | $0 |
| Tuyen Ong | 董事 | 2021年10月4日 A | — | 0 | 0 | $0 |
| James B. Tananbaum | 董事 | 2021年10月4日 A | — | 0 | 0 | $0 |
| Jason P Rhodes | 董事 | 2021年10月4日 A | — | 0 | 0 | $0 |
| GORDON CARL L | 董事 | 2021年10月4日 A | — | 0 | 0 | $0 |
| David Charles Lubner | 董事 | 2021年3月12日 A | — | 0 | 0 | $0 |
| Novo Holdings A/S | 10% 所有者 | 2023年6月28日 S | 1090772 | 0 | 0 | $0 |
| Jonathan Yen-Wen Yu | — | 2026年8月12日 M | 54324 | 0 | 11 | $-4833128 |
| Rahul Khara | — | 2026年8月6日 M | 52324 | 0 | 11 | $-1874683 |
| Precillia Redmond | — | 2021年2月5日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 6 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Atlas Venture Fund X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Fund XII, L.P., Atlas Venture Associates XII, L.P., Atlas Venture Associates XII, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LP, Atlas Venture Associates Opportunity II, LLC ×6 申报 | 2025年12月17日 | 2.20% | 修订 | — | SEC |
| AI DMI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik ×7 申报 | 2025年10月22日 | 8.00% | 修订 | 并购/出售 | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC ×6 申报 | 2025年3月12日 | 4.50% | 修订 | — | SEC |
| Adage Capital Partners, L.P., Adage Capital Partners GP, L.L.C., Adage Capital Advisors, L.L.C., Robert Atchinson, Phillip Gross ×3 申报 | 2023年2月16日 | — | 初始申报 | — | SEC |
| Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates, LLC, Lightstone Singapore, L.P., Lightstone Singapore Associates, LLC, Michael A. Carusi, Jean M. George, Henry A. Plain, Jr. ×2 申报 | 2023年2月14日 | — | 初始申报 | 并购/出售 | SEC |
| FS Development Holdings, LLC, Foresite Capital Fund V, L.P., Foresite Capital Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Opportunity Management V, LLC, James Tananbaum ×3 申报 | 2023年1月5日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 46 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 1.69% | 39334 NS | 2026年5月31日 | N-PORT |
| FMED · Fidelity Covington Trust | 1.18% | 6926 NS | 2026年5月31日 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 0.86% | 27470 SH | 2026年8月8日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.74% | 57978 NS | 2026年4月30日 | N-PORT |
| BBC · ETFis Series Trust I | 0.53% | 3004 NS | 2026年4月30日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 0.38% | 636 NS | 2026年4月30日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.20% | 2080 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.16% | 202771 SH | 2026年8月8日 | 每日 |
| IWO · iShares Trust | 0.13% | 254812 SH | 2026年8月8日 | 每日 |
| BIB · ProShares Trust | 0.13% | 1411 NS | 2026年5月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.12% | 30333 SH | 2026年8月8日 | 每日 |
| FFSM · FIDELITY COVINGTON TRUST | 0.10% | 19972 NS | 2026年4月30日 | N-PORT |
| ESSC · Strategy Shares | 0.09% | 356 NS | 2026年4月30日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.09% | 10028 NS | 2026年4月30日 | N-PORT |
| ISCG · iShares Trust | 0.09% | 11028 SH | 2026年8月8日 | 每日 |
| BKSE · BNY Mellon ETF Trust | 0.08% | 986 NS | 2026年4月30日 | N-PORT |
| IWM · iShares Trust | 0.07% | 724632 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 162749 SH | 2026年8月8日 | 每日 |
| ESML · iShares Trust | 0.06% | 20807 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.06% | 11910 NS | 2026年4月30日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.05% | 112189 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.05% | 1293 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 152195 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.04% | 1550 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.04% | 11895 SH | 2026年8月8日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 366845 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.03% | 74680 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.03% | 1011 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 11162 NS | 2026年4月30日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 8781 SH | 2026年8月8日 | 每日 |
| WSML · iShares Trust | 0.02% | 1824 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.02% | 1021 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 4076 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 60244 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 915 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 26 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 11918 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 7752 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 12978 NS | 2026年4月30日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 49447 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 8370 SH | 2026年8月8日 | 每日 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 18441 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 318 NS | 2026年4月30日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 971123 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2280 SH | 2026年8月8日 | 每日 |
| FTLS · First Trust Exchange-Traded Fund III | -0.03% | -10643 NS | 2026年4月30日 | N-PORT |